Seeking Alpha Quant rates LABU as a strong Sell, but I rates it as a Buy due to bullish market conditions. LABU is a leveraged ETF that seeks to track 3x the daily performance of the S&P Biotechnology ...
The Direxion Daily S&P Biotech Bull 3X Shares ETF (LABU) offers 3x daily leveraged exposure to the S&P Biotechnology Select Industry Index. LABU is highly liquid and popular among short-term traders, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback